(Q46533470)

22 December 2017

title

Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis (English)

1 reference

22 December 2017

1 reference

7

1 reference

22 December 2017

author name string

Roy Mathew

1

1 reference

22 December 2017

Stephen Futterweit

2

1 reference

22 December 2017

Elsa Valderrama

3

1 reference

22 December 2017

Antonio A Tarectecan

4

1 reference

22 December 2017

John E Bylander

5

1 reference

22 December 2017

Judith S Bond

6

1 reference

22 December 2017

publication date

7 June 2005

1 reference

22 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

22 December 2017

volume

289

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

F911-21

1 reference

22 December 2017

Add-on angiotensin receptor blockade with maximized ACE inhibition

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Clinical and cellular markers of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Characterization of the soluble, secreted form of urinary meprin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

The astacin family of metalloendopeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

The structural genes, MEP1A and MEP1B, for the alpha and beta subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Angiotensin II and its receptors in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Meprin, a brush-border enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Pathogenesis, prevention, and treatment of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Activation of renal signaling pathways in db/db mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Markers of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Genetics of diabetic nephropathy in the Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

An old enzyme with a new function: purification and characterization of a distinct matrix-degrading metalloproteinase in rat kidney cortex and its identification as meprin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Diabetic kidney disease in thedb/dbmouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Meprin activity in rats with experimental renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Meprin A, the major matrix degrading enzyme in renal tubules, produces a novel nidogen fragment in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00037.2005

10.1152/AJPRENAL.00037.2005

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15942051

1 reference

22 December 2017